157 related articles for article (PubMed ID: 332713)
1. Superoxide dismutase in Bacteroides fragilis and related Bacteroides species.
Carlsson J; Wrethén J; Beckman G
J Clin Microbiol; 1977 Sep; 6(3):280-4. PubMed ID: 332713
[TBL] [Abstract][Full Text] [Related]
2. Superoxide dismutase and O2 lethality in Bacteroides fragilis.
Privalle CT; Gregory EM
J Bacteriol; 1979 Apr; 138(1):139-45. PubMed ID: 438129
[TBL] [Abstract][Full Text] [Related]
3. In vivo metal substitution in Bacteroides fragilis superoxide dismutase.
Chen Y; Gregory EM
Free Radic Res Commun; 1991; 12-13 Pt 1():313-8. PubMed ID: 2071036
[TBL] [Abstract][Full Text] [Related]
4. Factors affecting production of catalase by Bacteroides.
Wilkins TD; Wagner DL; Veltri BJ; Gregory EM
J Clin Microbiol; 1978 Nov; 8(5):553-7. PubMed ID: 730827
[TBL] [Abstract][Full Text] [Related]
5. Encapsulated strains of Bacteroides fragilis in clinical specimens.
Lindberg AA; Berthold P; Nord CE; Weintraub A
Med Microbiol Immunol; 1979 Mar; 167(1):29-36. PubMed ID: 440201
[TBL] [Abstract][Full Text] [Related]
6. Pathogenicity of the Bacteroides fragilis group.
Brook I
Ann Clin Lab Sci; 1989; 19(5):360-76. PubMed ID: 2679351
[TBL] [Abstract][Full Text] [Related]
7. Superoxide dismutase in anaerobes: survey.
Gregory EM; Moore WE; Holdeman LV
Appl Environ Microbiol; 1978 May; 35(5):988-91. PubMed ID: 655716
[TBL] [Abstract][Full Text] [Related]
8. Characterization of cephalosporinases from Bacteroides fragilis, Bacteroides thetaiotaomicron and Bacteroides vulgatus.
Sato K; Matsuura Y; Miyata K; Inoue M; Mitsuhashi S
J Antibiot (Tokyo); 1983 Jan; 36(1):76-85. PubMed ID: 6332105
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility patterns and resistance to imipenem in the Bacteroides fragilis group species in Japan: a 4-year study.
Bandoh K; Ueno K; Watanabe K; Kato N
Clin Infect Dis; 1993 Jun; 16 Suppl 4():S382-6. PubMed ID: 8324152
[TBL] [Abstract][Full Text] [Related]
10. Recovery of Bacteroides fragilis group from clinical specimens following antimicrobial therapy.
Brook I; Frazier EH
Can J Microbiol; 1992 Mar; 38(3):226-9. PubMed ID: 1393825
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic susceptibility of the subspecies of Bacteroides fragilis.
Blazevic DJ
Antimicrob Agents Chemother; 1976 Mar; 9(3):481-4. PubMed ID: 1259403
[TBL] [Abstract][Full Text] [Related]
12. [Bacteroides and appendicitis (author's transl)].
Werner H; Kunstek-Santos H; Schockemöhle C; Gündürewa M
Pathol Microbiol (Basel); 1975; 42(2):110-8. PubMed ID: 1178229
[TBL] [Abstract][Full Text] [Related]
13. Identification of Bacteroides fragilis by indirect immunofluorescence.
Weintraub A; Lindberg AA; Nord CE
Med Microbiol Immunol; 1979; 167(4):223-30. PubMed ID: 94651
[TBL] [Abstract][Full Text] [Related]
14. Annual incidence, epidemiology, and comparative in vitro susceptibilities to cefoxitin, cefotetan, cefmetazole, and ceftizoxime of recent community-acquired isolates of the Bacteroides fragilis group.
Goldstein EJ; Citron DM
J Clin Microbiol; 1988 Nov; 26(11):2361-6. PubMed ID: 3235664
[TBL] [Abstract][Full Text] [Related]
15. Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres.
Jacobs MR; Spangler SK; Appelbaum PC
J Antimicrob Chemother; 1990 Sep; 26(3):361-70. PubMed ID: 2228827
[TBL] [Abstract][Full Text] [Related]
16. [Pathogenic factors in mixed infection due to Bacteroides fragilis and other species of bacteria in mice].
Miyazaki S; Ishii T; Tsuji A; Kitaya S; Kaneko Y; Ogawa M; Goto S
Nihon Saikingaku Zasshi; 1986 May; 41(3):611-7. PubMed ID: 3528556
[No Abstract] [Full Text] [Related]
17. Rapid identification of clinically important bacteroides by coagglutination method.
Lalitha MK; Anandi V; Elias L; Kalpana CR
Indian J Med Res; 1991 Mar; 93():98-102. PubMed ID: 1855827
[TBL] [Abstract][Full Text] [Related]
18. Heterologous expression of the Bacteroides ruminicola xylanase gene in Bacteroides fragilis and Bacteroides uniformis.
Whitehead TR; Hespell RB
FEMS Microbiol Lett; 1990 Jan; 54(1-3):61-5. PubMed ID: 2323546
[TBL] [Abstract][Full Text] [Related]
19. [Bacteroides fragilis group in non-diarrheal human feces and its antimicrobial susceptibility].
Rodríguez E; Gamboa MM; Rodríguez C; Vargas P
Rev Esp Quimioter; 2006 Dec; 19(4):357-62. PubMed ID: 17235405
[TBL] [Abstract][Full Text] [Related]
20. Specificity of immunoglobulin M antibodies in normal human serum that participate in opsonophagocytosis and intracellular killing of Bacteroides fragilis and Bacteroides thetaiotaomicron by by human polymorphonuclear leukocytes.
Bjornson AB; Bjornson HS; Kitko BP
Infect Immun; 1980 Oct; 30(1):263-71. PubMed ID: 6160104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
